Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron vs Aprepitant for PONV in Laparoscopic Surgery
NCT05632224Phase 4Unknown
- Sponsor
- Baskent University
- Start
- Nov 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant, granisetron in postoperative nausea and vomiting (PONV), sponsored by Baskent University. Status: unknown.
02
Drugs
aprepitantgranisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05632224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05632224.